Gene expression in human chondrocytes in late osteoarthritis is changed in both fibrillated and intact cartilage without evidence of generalised chondrocyte hypertrophy

Annals of the Rheumatic Diseases

Volumn 69, Issue 1, 2010, Pages 234-240

  Brew, C J ^a   Clegg, P D ^a,b   Boot Handford, R P ^a   Andrew, J G ^c   Hardingham, T ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c YSBYTY GWYNEDD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; COLLAGEN TYPE 1; COLLAGEN TYPE 10; COLLAGEN TYPE 2; COLLAGENASE 3; MATRILIN 1; PARATHYROID HORMONE RELATED PROTEIN RECEPTOR; SCLEROPROTEIN; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGED; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE; CARTILAGE CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GROWTH PLATE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTROPHY; MALE; OSTEOARTHRITIS; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; UPREGULATION;

AGED; AGED, 80 AND OVER; AGGRECANS; CARTILAGE, ARTICULAR; CHONDROCYTES; COLLAGEN; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; HYPERTROPHY; KNEE JOINT; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; RNA, MESSENGER; SOX9 TRANSCRIPTION FACTOR; WEIGHT-BEARING;

EID: 73449143498     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2008.097139     Document Type: Article

References (49)

1. Mollenhauer JA, Erdmann S. Introduction: molecular and biomechanical basis of osteoarthritis. Cell Mol Life Sci 2002;59:3.
2. Hardingham T. Extracellular matrix and pathogenic mechanisms in osteoarthritis. Curr Rheumatol Rep 2008;10:30-6.
3. Miranda H, Viikari-Juntura E, Martikainen R, et al. A prospective study on knee pain and its risk factors. Osteoarthritis Cartilage 2002;10:623-30.
4. Karlson EW, Mandl LA, Aweh GN, et al. Total hip replacement due to osteoarthritis: the importance of age, obesity, and other modifiable risk factors. Am J Med 2003;114:93-8.
5. Matyas JR, Huang D, Chung M, et al. Regional quantification of cartilage type II collagen and aggrecan messenger RNA in joints with early experimental osteoarthritis. Arthritis Rheum 2002;46:1536-43.
6. Gebhard PM, Gehrsitz A, Bau B, et al. Quantification of expression levels of cellular differentiation markers does not support a general shift in the cellular phenotype of osteoarthritic chondrocytes. J Orthop Res 2003;21:96-101.
7. Bau B, Gebhard PM, Haag J, et al. Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. Arthritis Rheum 2002;46:2648- 57.
8. Kaiser M, Haag J, Söder S, et al. Bone morphogenetic protein and transforming growth factor beta inhibitory Smads 6 and 7 are expressed in human adult normal and osteoarthritic cartilage in vivo and are differentially regulated in vitro by interleukin-1beta. Arthritis Rheum 2004;50:3535-40.
9. Aigner T, Fundel K, Saas J, et al. Large-scale gene expression profiling reveals major pathogenetic pathways of cartilage degeneration in osteoarthritis. Arthritis Rheum 2006;54:3533-44.
10. Aigner T, Reichenberger E, Bertling W, et al. Type X collagen expression in osteoarthritic and rheumatoid articular cartilage. Virchows Arch B Cell Pathol Incl Mol Pathol 1993;63:205-11.
11. Girkontaite I, Frischholz S, Lammi P, et al. Immunolocalization of type X collagen in normal fetal and adult osteoarthritic cartilage with monoclonal antibodies. Matrix Biol 1996;15:231-8.
12. von der Mark MK, Kirsch T, Nerlich A, et al. Type X collagen synthesis in human osteoarthritic cartilage. Indication of chondrocyte hypertrophy. Arthritis Rheum 1992;35:806-11.
13. Walker GD, Fischer M, Gannon J, et al. Expression of type-X collagen in osteoarthritis. J Orthop Res 1995;13:4-12.
14. Hoyland JA, Thomas JT, Donn R, et al. Distribution of type X collagen mRNA in normal and osteoarthritic human cartilage. Bone Miner 1991;15:151-63.
15. Pufe T, Petersen W, Tillmann B, et al. The splice variants VEGF121 and VEGF189 of the angiogenic peptide vascular endothelial growth factor are expressed in osteoarthritic cartilage. Arthritis Rheum 2001;44:1082-8.
16. Pfander D, Kortje D, Zimmermann R, et al. et al. Vascular endothelial growth factor in articular cartilage of healthy and osteoarthritic human knee joints. Ann Rheum Dis 2001;60:1070-3.
17. Enomoto H, Inoki I, Komiya K, et al. Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage. Am J Pathol 2003;162:171-81.
18. White A, Watson R, Newman B, et al. Annexin VIII is differentially expressed by chondrocytes in the mammalian growth plate during endochondral ossification and in osteoarthritic cartilage. J Bone Miner Res 2002;17:1851-8.
19. Yang X, Chen L, Xu X, et al. TGF-{beta}/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. J Cell Biol 2001;153:35-46.
20. Serra R, Johnson M, Filvaroff EH, et al. Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. J Cell Biol 1997;139:541-52.
21. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957;16:494-502.
22. Al-Taher A, Bashein A, Nolan T, et al. Global cDNA amplification combined with realtime RT-PCR: accurate quantification of multiple human potassium channel genes at the single cell level. Yeast 2000;17:201-10.
23. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-[delta][delta]CT method. Methods 2001;25:402-8.
24. Freemont AJ, Hampson V, Tilman R, et al. Gene expression of matrix metalloproteinases 1, 3, and 9 by chondrocytes in osteoarthritic human knee articular cartilage is zone and grade specific. Ann Rheum Dis 1997;56:542-8.
25. Tchetina EV, Squires G, Poole AR. Increased type II collagen degradation and very early focal cartilage degeneration is associated with upregulation of chondrocyte differentiation related genes in early human articular cartilage lesions. J Rheumatol 2005;32:876-86.
26. Aigner T, Gebhard PM, Schmid E, et al. SOX9 expression does not correlate with type II collagen expression in adult articular chondrocytes. Matrix Biol 2003;22:363-72.
27. Ijiri K, Zerbini LF, Peng H, et al. Differential expression of GADD45 beta in normal and osteoarthritic cartilage - potential role in homeostasis of articular chondrocytes. Arthritis Rheum 2008;58:2075-87.
28. Lorenz H, Wenz W, Ivancic M, et al. Early and stable upregulation of collagen type II, collagen type I and YKL40 expression levels in cartilage during early experimental osteoarthritis occurs independent of joint location and histological grading. Arthritis Res Ther 2005;7:R156-65.
29. Lorenz H, Richter W. Osteoarthritis: Cellular and molecular changes in degenerating cartilage. Progr Histochem Cytochem 2006;40:135-63.
30. Chen Q, Johnson DM, Haudenschild DR, et al. Progression and recapitulation of the chondrocyte differentiation program: cartilage matrix protein is a marker for cartilage maturation. Dev Biol 1995;172:293-306.
31. Amling M, Neff L, Tanaka S, et al. Bcl-2 lies downstream of parathyroid hormone-related peptide in a signaling pathway that regulates chondrocyte maturation during skeletal development. J Cell Biol 1997;136:205-13.
32. Lanske B, Karaplis AC, Lee K, et al. PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science 1996;273:663-6.
33. Stickens D, Behonick DJ, Ortega N, et al. Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development 2004;131:5883-95.
34. Gerber HP, Vu TH, Ryan AM, et al. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999;5:623-8.
35. Kamekura S, Hoshi K, Shimoaka T, et al. Osteoarthritis development in novel experimental mouse models induced by knee joint instability. Osteoarthritis Cartilage 2005;13:632-41.
36. Yagi R, McBurney D, Laverty D, et al. Intrajoint comparisons of gene expression patterns in human osteoarthritis suggest a change in chondrocyte phenotype. J Orthop Res 2005;23:1128-38.
37. Sato T, Konomi K, Yamasaki S, et al. Comparative analysis of gene, expression profiles in intact and damaged regions of human osteoarthritic cartilage. Arthritis Rheum 2006;54:808-17.
38. Lefebvre V, Huang W, Harley VR, et al. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol 1997;17:2336-46.
39. Lefebvre V, de Crombrugghe B. Toward understanding SOX9 function in chondrocyte differentiation. Matrix Biol 1998;16:529-40.
40. Carney SL, Billingham ME, Muir H, et al. Demonstration of increased proteoglycan turnover in cartilage explants from dogs with experimental osteoarthritis. J Orthop Res 1984;2:201-6.
41. Sandy JD, Adams ME, Billingham ME, et al. In vivo and in vitro stimulation of chondrocyte biosynthetic activity in early experimental osteoarthritis. Arthritis Rheum 1984;27:388-97.
42. Carney SL, Billingham ME, Caterson B, et al. Changes in proteoglycan turnover in experimental canine osteoarthritic cartilage. Matrix 1992;12:137-47.
43. Matyas JR, Adams ME, Huang D, et al. Discoordinate gene expression of aggrecan and type II collagen in experimental osteoarthritis. Arthritis Rheum 1995;38:420-5.
44. Matyas JR, Ehlers PF, Huang D, et al. The early molecular natural history of experimental osteoarthritis. I. Progressive discoordinate expression of aggrecan and type II procollagen messenger RNA in the articular cartilage of adult animals. Arthritis Rheum 1999;42:993-1002.
45. Matyas JR, Huang D, Chung M, et al. Regional quantification of cartilage type II collagen and aggrecan messenger RNA in joints with early experimental osteoarthritis. Arthritis Rheum 2002;46:1536-43.
46. Pelletier J-P, Boileau C, Boily M, et al. The protective effect of licofelone on experimental osteoarthritis is correlated with the downregulation of gene expression and protein synthesis of several major cartilage catabolic factors: MMP-13, cathepsin K and aggrecanases. Arthritis Res Ther 2005;7:R1091-102.
47. Conrozier T, Ferrand F, Poole AR, et al. Differences in biomarkers of type II collagen in atrophic and hypertrophic osteoarthritis of the hip: implications for the differing pathobiologies. Osteoarthritis Cartilage 2007;15:462-7.
48. Tew SR, Li Y, Pothacharoen P, et al. Retroviral transduction with SOX9 enhances reexpression of the chondrocyte phenotype in passaged osteoarthritic human articular chondrocytes. Osteoarthritis Cartilage 2005;13:80-9.
49. Cucchiarini M, Thurn T, Weimer A, et al. Restoration of the extracellular matrix in human osteoarthritic articular cartilage by overexpression of the transcription factor Sox9. Arthritis Rheumatism 2007;56:158-67.